Relative Survival Rates of Pediatric Patients with Solid Tumours in Khon Kaen, Thailand.

Q2 Medicine

Asian Pacific Journal of Cancer Prevention Pub Date : 2026-09-01 DOI:10.31557/APJCP.2026.27.9.3341

Surachai Phimha, Prapassara Sirikarn, Chanaporn Pinsuwan, Chalongpon Santong, Su-On Chainansamit, Patcharee Komvilaisak, Kunanya Suwannaying

{"title":"Relative Survival Rates of Pediatric Patients with Solid Tumours in Khon Kaen, Thailand.","authors":"Surachai Phimha, Prapassara Sirikarn, Chanaporn Pinsuwan, Chalongpon Santong, Su-On Chainansamit, Patcharee Komvilaisak, Kunanya Suwannaying","doi":"10.31557/APJCP.2026.27.9.3341","DOIUrl":null,"url":null,"abstract":"Background: Pediatric solid tumours constitute a subgroup of childhood cancers that continue to pose a significant global health challenge due to limitations in diagnostic techniques and treatment options. This study aimed to explore the relative survival rates of patients with childhood cancer over two decades using population-based data from a cancer registry.Methods: This population-based study included pediatric patients with cancer in Khon Kaen, Thailand, and focused on children under 15 years of age who were diagnosed with solid tumours from January 1st, 2000, through December 31st, 2019. A total of 371 childhood solid tumours were diagnosed in Khon Kaen during the study period, with follow-up through 2021. Survival analysis was conducted via relative survival rate (RSR) estimates.Results: The most common solid tumours were CNS and miscellaneous intracranial and intraspinal neoplasms (27.7%). The overall 5-year RSR for pediatric patients with solid tumours was 0.57 (95% CI: 0.52-0.62). Compared with male patients, female patients had higher 5-year RSRs (0.62, 95% CI: 0.53-0.68 versus 0.53, 95% CI: 0.46-0.60). Survival improved over time, with patients diagnosed between 2010 and 2019 having better 5-year RSRs than those diagnosed from 2000 to 2009 did (0.59, 95% CI: 0.52-0.66 and 0.55, 95% CI: 0.47-0.62, respectively).Conclusions: In conclusion, better outcomes were observed among females, patients living closer to health care facilities and those diagnosed in the more recent decade (2010-2019).","PeriodicalId":55451,"journal":{"name":"Asian Pacific Journal of Cancer Prevention","volume":"27 9","pages":"3341-3348"},"PeriodicalIF":0.0000,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asian Pacific Journal of Cancer Prevention","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31557/APJCP.2026.27.9.3341","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Pediatric solid tumours constitute a subgroup of childhood cancers that continue to pose a significant global health challenge due to limitations in diagnostic techniques and treatment options. This study aimed to explore the relative survival rates of patients with childhood cancer over two decades using population-based data from a cancer registry.

Methods: This population-based study included pediatric patients with cancer in Khon Kaen, Thailand, and focused on children under 15 years of age who were diagnosed with solid tumours from January 1st, 2000, through December 31st, 2019. A total of 371 childhood solid tumours were diagnosed in Khon Kaen during the study period, with follow-up through 2021. Survival analysis was conducted via relative survival rate (RSR) estimates.

Results: The most common solid tumours were CNS and miscellaneous intracranial and intraspinal neoplasms (27.7%). The overall 5-year RSR for pediatric patients with solid tumours was 0.57 (95% CI: 0.52-0.62). Compared with male patients, female patients had higher 5-year RSRs (0.62, 95% CI: 0.53-0.68 versus 0.53, 95% CI: 0.46-0.60). Survival improved over time, with patients diagnosed between 2010 and 2019 having better 5-year RSRs than those diagnosed from 2000 to 2009 did (0.59, 95% CI: 0.52-0.66 and 0.55, 95% CI: 0.47-0.62, respectively).

Conclusions: In conclusion, better outcomes were observed among females, patients living closer to health care facilities and those diagnosed in the more recent decade (2010-2019).

查看原文本刊更多论文

泰国孔敬地区儿童实体瘤患者的相对存活率

背景：儿童实体瘤是儿童癌症的一个亚组，由于诊断技术和治疗方案的限制，它继续对全球健康构成重大挑战。本研究旨在利用来自癌症登记处的基于人群的数据，探讨儿童癌症患者在20多年中的相对存活率。方法：这项基于人群的研究纳入了泰国Khon Kaen的儿童癌症患者，重点关注2000年1月1日至2019年12月31日期间被诊断患有实体瘤的15岁以下儿童。在研究期间，孔敬县共诊断出371例儿童实体肿瘤，随访至2021年。通过相对存活率（RSR）估计进行生存分析。结果：以中枢神经系统和杂项颅内及椎管内肿瘤居多（27.7%）。儿童实体瘤患者的总体5年RSR为0.57 （95% CI: 0.52-0.62）。与男性患者相比，女性患者的5年rrs更高（0.62,95% CI: 0.53-0.68 vs 0.53, 95% CI: 0.46-0.60）。生存率随着时间的推移而提高，2010年至2019年诊断的患者的5年rrs优于2000年至2009年诊断的患者（分别为0.59,95% CI: 0.52-0.66和0.55,95% CI: 0.47-0.62）。结论：综上所述，女性、离医疗机构较近的患者以及近十年（2010-2019年）确诊的患者预后较好。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Asian Pacific Journal of Cancer Prevention 医学-肿瘤学

CiteScore

2.80

自引率

0.00%

发文量

779

审稿时长

3 months

期刊介绍： Cancer is a very complex disease. While many aspects of carcinoge-nesis and oncogenesis are known, cancer control and prevention at the community level is however still in its infancy. Much more work needs to be done and many more steps need to be taken before effective strategies are developed. The multidisciplinary approaches and efforts to understand and control cancer in an effective and efficient manner, require highly trained scientists in all branches of the cancer sciences, from cellular and molecular aspects to patient care and palliation. The Asia Pacific Organization for Cancer Prevention (APOCP) and its official publication, the Asia Pacific Journal of Cancer Prevention (APJCP), have served the community of cancer scientists very well and intends to continue to serve in this capacity to the best of its abilities. One of the objectives of the APOCP is to provide all relevant and current scientific information on the whole spectrum of cancer sciences. They aim to do this by providing a forum for communication and propagation of original and innovative research findings that have relevance to understanding the etiology, progression, treatment, and survival of patients, through their journal. The APJCP with its distinguished, diverse, and Asia-wide team of editors, reviewers, and readers, ensure the highest standards of research communication within the cancer sciences community across Asia as well as globally. The APJCP publishes original research results under the following categories: -Epidemiology, detection and screening. -Cellular research and bio-markers. -Identification of bio-targets and agents with novel mechanisms of action. -Optimal clinical use of existing anti-cancer agents, including combination therapies. -Radiation and surgery. -Palliative care. -Patient adherence, quality of life, satisfaction. -Health economic evaluations.